Submit a Referral

Online Bill Pay

Facing Hyperlipidemia Together,
Moving Forward Stronger

Putting You at the Center of High-Quality Infusion Care

At Infusion for Health, we provide advanced infusion therapies to help manage Hyperlipidemia (HLD) by reducing symptoms, slowing progression, and improving quality of life — all in a safe, comfortable, and supportive environment.

 

What is Hyperlipidemia (HLD)?

HLD is a condition that involves elevated amounts of lipids (fats) in the bloodstream, including cholesterol and triglycerides. Over time, these fats can build up within the arteries, leading to plaque formation and raising the risk of cardiovascular complications, such as heart attacks and strokes.

The condition usually has no symptoms. The only way to know if you are at risk is through a blood test for cholesterol levels, called a lipid panel.

Injection Therapies

Injection therapies are a cornerstone in managing HLD and minimizing cardiovascular events when lifestyle modifications, diet changes, and oral medications are not effective in lowering your cholesterol. Your doctor may prescribe an add-on injection therapy called Leqvio. This treatment is administered in our clinics and is closely monitored by our expert care team to ensure your comfort and safety. Injection therapy may help:

  • Reduce risk of cardiovascular events
  • Lower risk of heart disease
  • Lower cholesterol levels
  • Improve cardiovascular health

 

Care That Goes Beyond Treatment

Living with a chronic condition is about more than managing symptoms — it’s about maintaining hope, independence, and peace of mind. Whether you receive treatment in our state-of-the-art centers or, if eligible, from the comfort and convenience of your own home, Infusion for Health is here to support you every step of the way.

Therapies We Provide

References

  1. High cholesterol. (2025, March 7). Mayo Clinic. Retrieved September 19, 2025, from https://www.mayoclinic.org/diseases-conditions/high-blood-cholesterol/symptoms-causes/syc-20350800

  2. Canadian Agency for Drugs and Technologies in Health. (2024, May). Inclisiran (Leqvio). National Library of Medicine. Retrieved September 19, 2025, from https://www.ncbi.nlm.nih.gov/books/NBK604817/

  3. Novartis. (2025). Cholesterol-Lowering Injection | LEQVIO® (inclisiran). Retrieved September 19, 2025, from https://www.leqvio.com/

  4. O’Riordan, M. (2025, August 6). Inclisiran gains indication as stand-alone therapy to reduce LDL cholesterol [Press release]. TCTMD.com. Retrieved September 19, 2025, from https://www.tctmd.com/news/inclisiran-gains-indication-stand-alone-therapy-reduce-ldl-cholesterol

Discover an infusion center close to you

Find a Location

Discover an infusion center close to you

Find a Location
Infusion For Health
Powered by  GDPR Cookie Compliance
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.